Nuvilex Inc. Reminiscent of Major Biotech Success Stories

On May 14, 2013, Goldman Small Cap Research published an Article on Nuvilex, Inc. (OTCQB – NVLX).

Read more...
 
A Rare Bargain

Today we are issuing an updated report on LIG Assets (LIGA). LIG Assets may be one of the most successful opportunistic investors and financiers of its size and its strategy could result in $3-4M in net profit this year. Such a return is 4x the current market cap, making LIG’s share price a rare bargain.

Read more...
 
Nuvilex Inc. Affiliate Readies for Future Clinical Trials

Nuvilex Inc. Affiliate Readies for Future Clinical Trials

Read more...
 
The Next Takeover Target
RealBiz Media Group, Inc. is on the cutting edge of a fast-growing, high value digital media platform for the real estate industry. Based on recent transactions we believe RBIZ could emerge as the next takeover candidate in the space. Our target is $4.00.
Read more...
 
Multiple Indications Equals Tens of Billions in Market Size for Nuvilex, Inc.

Nuvilex, Inc. (OTCQB – NVLX) is no one-trick pony. The Company’s live-cell encapsulation drug delivery platform has already demonstrated that it can significantly improve the efficacy and safety results in mid-stage clinical trial studies in patients in advanced stages of pancreatic cancer. But, as the development progresses, it is not inconceivable that the size of the market for platform reaches the tens of billions worldwide. 

Read more...
 
NVLX: Another State Makes It Official

Late last week, Governor Martin O’Malley made it official. Following a public bill-signing ceremony, the State of Maryland will now become the 19th state in the Union to approve a medical marijuana program.

Read more...
 
NVLX: Broader Medical Marijuana Research Forges Ahead

Broader Medical Marijuana Research Forges Ahead

Read more...
 
Rising LED Lighting Leader

It is clear that FNRG is an underfollowed and relative unknown in the LED market. However, as the Company hits on some of what we believe could be nearly $100M in projects up for bid, the stock could quickly trade to the $9.00 level.

Read more...
 
NVLX and Other Oncology Stocks on Fire
NVLX & Other Small Cap Oncology Stocks on Fire Leading Up to ASCO Meeting
Read more...
 
Could FAB Move Like Netflix?

Following a review of FAB’s Libsyn subscriber numbers and Netflix’s (NASDAQ – NFLX) subscriber growth and valuation methodology we believe that a case can be made that FAB’s Libsyn division could be worth $150M or more.

Read more...
 
<< Start < Prev 31 32 33 34 35 36 37 38 39 40 Next > End >>

Page 34 of 40